Fine-tuning our diagnosis and treatment of depression

Journal of Psychiatric Research

Volumn 40, Issue 4, 2006, Pages 281-282

  Ohayon, Maurice M ^a   Schatzberg, Alan F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; IODINE 123;

BRAIN FUNCTION; CLINICAL EXAMINATION; CLINICAL TRIAL; DEPRESSION; DISABILITY; EDITORIAL; EUROPE; EVALUATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 33646384373     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.04.005     Document Type: Editorial

References (14)

1. Bajbouj M., Lang U.E., Niehaus L., Hellen F.E., Heuser I., and Neu P. Effects of right unilateral electroconvulsive therapy on motor cortical excitability in depressive patients. Journal of Psychiatry Research 40 (2006)
2. Cross-National Collaborative Group. The changing rate of major depression. Cross-national comparisons. Cross-National Collaborative Group. JAMA. 1992;268:3098-105.
3. Fava M., Detke M.J., Balestrieri M., Wang F., Raskin J., and Perahia D. Management of depression relapse: re-initiation of duloxetine treatment or dose increase. Journal of Psychiatry Reasarch 40 (2006)
4. Mallinckrodt C.H., Prakash A., Andorn A.C., Watkin J.G., and Wohlreich M.H. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range. Journal of Psychiatry Research 40 (2006)
5. Murray C.J., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349 (1997) 1436-1442
6. Ohayon M.M., and Schatzberg A.F. Using chronic pain to predict depressive morbidity in the general population. Archives of General Psychiatry 60 (2003) 39-47
7. 123I]-IBZM SPECT study. Journal of Psychiatry Research 40 (2006)
8. Reynolds III C.F., Dew M.A., Pollock B.G., Mulsant B.H., Frank E., Miller M.D., et al. Maintenance treatment of major depression in old age. New England Journal of Medicine 354 (2006) 1130-1138
9. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, et al., Fava M; STAR*D Study Team. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England of Journal of Medicine 2006;354:1231-42.
10. Schreier A., Hofler M., Wittchen H.U., and Lieb R. Clinical characteristics of major depressive disorder run in families - a community study of 933 mothers and their children. Journal of Psychiatry Research 40 (2006)
11. Tollkotter M., Pfleiderer B., Soros P., and Michael N. Effects of antidepressive therapy on auditory processing in severely depressed patients: A combined MRS and MEG study. Journal of Psychiatry Research 40 (2006)
12. Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, et al., STAR*D Study Team. Medication augmentation after the failure of SSRIs for depression. New England Journal of Medicine 2006;354:1243-52.
13. Ustun T.B., Ayuso-Mateos J.L., Chatterji S., Mathers C., and Murray C.J. Global burden of depressive disorders in the year 2000. British Journal of Psychiatry 184 (2004) 386-392
14. Wagner M., Rihs T.A., Mosimann U.P., Fisch H.U., and Schlaepfer T.E. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex affects divided attention immediately after cessation of stimulation. Journal of Psychiatry Research 40 (2006)